hMG
Human menopausal gonadotropin is a mixture providing follicle-stimulating and luteinizing hormone activity in specific menotropin prescription products; it is not one peptide.
The short version
- Why people discuss it
- Discussed for male fertility and sperm production, often alongside hCG; female ovarian stimulation uses different regimens. Community interest does not establish benefit or a suitable treatment.
- What it is
- Human menopausal gonadotropin is a mixture providing follicle-stimulating and luteinizing hormone activity in specific menotropin prescription products; it is not one peptide.
- Biggest caution
- Menotropin regimens are indication-, product- and patient-specific and require clinical monitoring. Fertility-product evidence does not establish a bodybuilding or hormone-optimization protocol.
- Stack context
- Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.
Dose and frequency reference
Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.
Source agreement describes reported practice, not clinical validation.
Subcutaneous or intramuscular injection
Community reference · Not clinical guidance- Amount
- 75 IU
- Frequency
- 3 times weekly
- Duration / phase
- Often 12–24 months in monitored male-fertility protocols
Male-fertility context. A new publisher gives a 12–16-week example, whereas monitored treatment may span 12–24 months. Those different time horizons are not interchangeable with female ovarian-stimulation schedules. Reference only; this does not establish safety, effectiveness or individual suitability.
Reference source · reviewed 2026-09-12Compare reported schedules
Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.
- PeptideDosages — saved source reviewed September 27, 2026
75 IU SC three times/week for 12 weeks, optional 16; introduction says weekly inconsistently.
Evidence & sources · Community source profile
AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.
- AxonRep community research synthesisAxonRep synthesis · Checked 2026-09-12
- DailyMed: Menopur menotropins prescribing informationProduct label · Checked 2026-09-12
- PeptideDosages — saved source reviewed September 27, 2026Community reference · Checked 2026-09-27